Zenas Biopharma, Common Etf Technical Analysis
| ZBIO Etf | USD 8.06 1.05 11.53% |
As of the 26th of March, Zenas BioPharma, maintains the Standard Deviation of 6.54, market risk adjusted performance of (0.43), and Mean Deviation of 4.91. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zenas BioPharma, Common, as well as the relationship between them.
Zenas BioPharma, Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Zenas, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ZenasZenas |
Zenas BioPharma, technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Zenas BioPharma, Common Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Zenas BioPharma, Common volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Zenas BioPharma, Common Trend Analysis
Use this graph to draw trend lines for Zenas BioPharma, Common. You can use it to identify possible trend reversals for Zenas BioPharma, as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Zenas BioPharma, price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Zenas BioPharma, Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Zenas BioPharma, Common applied against its price change over selected period. The best fit line has a slop of 0.02 , which may suggest that Zenas BioPharma, Common market price will keep on failing further. It has 122 observation points and a regression sum of squares at 13.19, which is the sum of squared deviations for the predicted Zenas BioPharma, price change compared to its average price change.About Zenas BioPharma, Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Zenas BioPharma, Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Zenas BioPharma, Common based on its technical analysis. In general, a bottom-up approach, as applied to this etf, focuses on Zenas BioPharma, Common price pattern first instead of the macroeconomic environment surrounding Zenas BioPharma, Common. By analyzing Zenas BioPharma,'s financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Zenas BioPharma,'s intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Zenas BioPharma, specific price patterns or momentum indicators. Please read more on our technical analysis page.
Zenas BioPharma, March 26, 2025 Technical Indicators
Most technical analysis of Zenas help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zenas from various momentum indicators to cycle indicators. When you analyze Zenas charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.43) | |||
| Mean Deviation | 4.91 | |||
| Coefficient Of Variation | (4,244) | |||
| Standard Deviation | 6.54 | |||
| Variance | 42.83 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | (0.44) | |||
| Maximum Drawdown | 31.93 | |||
| Value At Risk | (10.47) | |||
| Potential Upside | 11.76 | |||
| Skewness | 0.6242 | |||
| Kurtosis | 1.21 |
Zenas BioPharma, March 26, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Zenas stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 35,636 | ||
| Daily Balance Of Power | (0.83) | ||
| Rate Of Daily Change | 0.88 | ||
| Day Median Price | 8.47 | ||
| Day Typical Price | 8.33 | ||
| Price Action Indicator | (0.93) |
Other Information on Investing in Zenas Etf
Zenas BioPharma, financial ratios help investors to determine whether Zenas Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zenas with respect to the benefits of owning Zenas BioPharma, security.